Leucovorin in Colorectal Cancer Treatment
Indications and Dosage
- The National Comprehensive Cancer Network recommends leucovorin 400 mg/m² IV over 2 hours on day 1, followed by 5-FU bolus and continuous infusion, repeated every 2 weeks, as part of the FOLFOX regimen for advanced colorectal cancer 1, 2, 3
- Leucovorin 400 mg/m² is equivalent to levo-leucovorin 200 mg/m², as stated by the National Comprehensive Cancer Network 1, 2, 3
Mechanism of Action and Efficacy
- The National Comprehensive Cancer Network notes that leucovorin stabilizes the binding of 5-FU metabolites to thymidylate synthase, enhancing 5-FU's cytotoxic effect in colorectal cancer 1, 6
- FOLFOX and FOLFIRI regimens containing leucovorin with 5-FU are standard first-line therapies for advanced colorectal cancer, prolonging survival compared to 5-FU alone, according to the National Comprehensive Cancer Network 1, 2, 7
Monitoring and Adverse Effects
- Regular monitoring of complete blood count is essential for early detection of hematologic toxicity, as recommended by Praxis Medical Insights 8
- Monitoring of liver and renal function is necessary during therapy to detect early signs of toxicity, according to Praxis Medical Insights 8
- Methotrexate levels should be monitored when using leucovorin for methotrexate rescue, to guide leucovorin dosing, as stated by Praxis Medical Insights 4